EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 31-May-2026 18:15 ET (31-May-2026 22:15 GMT/UTC)

Innovative targeted therapy halts prostate cancer spread to the bone

Virginia Commonwealth University
Peer-Reviewed Publication

New findings out of VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine show that an innovative drug effectively prevents prostate tumors from spreading to an advanced and incurable stage in the bones. The targeted small molecule inhibitor, IVMT-Rx-4, also enhances standard-of-care chemotherapy treatment for the disease, offering significant potential for a paradigm shift in the treatment of metastatic tumors.

Journal: Pharmacological Research
Funder: Virginia Commonwealth University, Commonwealth Health Research Board

Targeting MD2 could limit prostate cancer bone metastasis

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — April 1, 2026 — A new research perspective was published in Volume 13 of Oncoscience on March 11, 2026, titled “Targeting MD2 in prostate cancer bone metastasis: Mechanistic insights and therapeutic potential.”

Journal: Oncoscience

Doctors group files legal petition urging USDA to require colorectal cancer warning labels on processed meat

Physicians Committee for Responsible Medicine
Reports and Proceedings

To help protect Americans from colorectal cancer, which is now the leading cause of cancer death for people under 50, the Physicians Committee for Responsible Medicine filed a legal petition today urging the U.S. Department of Agriculture to require warning labels on processed meat and poultry products, such as bacon, deli meat, and hot dogs, which have been classified as “carcinogenic to humans” because of their link to colorectal cancer.

Lehigh University College of Health launches heal service center, a shared-high resolution mass spectrometry resource

Lehigh University
Business Announcement

Lehigh University’s College of Health is proud to announce the official launch of the Health and Environmental Assessment Laboratory (HEAL) Service Center. Situated in the state-of-the-art Health, Science, and Technology (HST) building, this university shared core facility is designed to be a powerhouse of molecular analysis, providing real-world solutions at the complex intersection of environment and human health.

Global Virus Network launches expanded “Global Guardians for Pandemic Preparedness” program for Florida high school students

Global Virus Network
Business Announcement

GVN announced the launch of its expanded Global Guardians for Pandemic Preparedness initiative, with applications now open for high school students across the state of Florida. The program is offered in partnership with the University of South Florida (USF), which also hosts GVN’s international headquarters.

USC physician-scientist Mohamed Abou-el-Enein named Outstanding New Investigator by the American Society of Gene + Cell Therapy

Keck School of Medicine of USC
Grant and Award Announcement

USC physician-scientist Mohamed Abou-el-Enein, MD, PhD, has found himself in a win-win situation: winning not one but two awards from the American Society of Gene + Cell Therapy (ASGCT), the leading professional organization in the field.

The first award celebrates Abou-el-Enein as a 2026 Outstanding New Investigator based on his contributions to the field of gene and cell therapy within the first 10 years of his career as an independent investigator.

The second, the 2026 Best of Molecular Therapy Award, honors a paper from his lab that demonstrates exceptional novelty, innovation and scientific significance. This year’s award recognizes “High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing” by first author Amaia Cadinanos-Garai. Additional authors are Christian L. Flugel, Anson Cheung, Enzi Jiang and Alix Vaissié from the Abou-el-Enein Lab and USC/Children’s Hospital Los Angeles (CHLA) Cell Therapy Program.

Meeting: ASGCT 2026 Annual Meeting

Changes in clinician time expenditure and visit quantity with adoption of AI–powered scribes

JAMA Network
Peer-Reviewed Publication

About The Study: AI scribe adoption was associated with modest decreases in total electronic health record time and documentation time and with a modest increase in weekly visit volume.

Journal: JAMA

Advertising payments to news websites that publish health misinformation

JAMA Network
Peer-Reviewed Publication

About The Study: From 2021 to 2024, government and health organizations accounted for about one-tenth of the $336 million in estimated advertising payments made to 11 news websites identified for publishing health misinformation. Noteworthy advertisers included federal health agencies, such as the Centers for Disease Control and Prevention, and pharmaceutical companies, such as Pfizer, although their individual contributions represented a small share of all payments.

Journal: JAMA Network Open

Mirtazapine for methamphetamine use disorder

JAMA Network
Peer-Reviewed Publication

About The Study: In this parallel-group randomized clinical trial, the generic tetracyclic antidepressant mirtazapine delivered in routine clinical practice reduced methamphetamine use in adults with methamphetamine use disorder. No unexpected safety concerns delivering mirtazapine in this setting were found; this finding has important clinical implications in the absence of any approved pharmacotherapies for methamphetamine use disorder.

Journal: JAMA Psychiatry